Despite advances in early detection and treatment, breast cancer remains the second leading cause of cancer-related death for females in the USA.1,2 In routine clinical practice, breast cancers are classified based on the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2). This evidence concerns the gene ERBB2 and breast cancer.